HF
TRAW icon

HRT Financial’s Traws Pharma TRAW Stock Holding History

HRT Financial’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,573
Closed -$23K – 4214
2025
Q3 		$23K Buy
+12,573
New +$20.5K ﹤0.01% 2693
2021
Q2 		– Sell
-1,772
Closed -$663K – 3651
2021
Q1 		$663K Buy
1,772
+1,637
+1,213% +$617K 0.01% 1564
2020
Q4 		$23K Sell
135
-930
-87% -$108K ﹤0.01% 1741
2020
Q3 		$111K Buy
1,065
+1,019
+2,215% +$252K ﹤0.01% 1503
2020
Q2 		$9K Buy
+46
New +$7.03K ﹤0.01% 1474
2020
Q1 		– Sell
-61
Closed -$8K – 1438
2019
Q4 		$8K Buy
+61
New +$11.4K ﹤0.01% 1096

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial's TRAW Position: Q4 2025 in Review

HRT Financial sold out of Traws Pharma (TRAW) in Q4 2025, closing a stake of 12,573 shares — an estimated $23K sold.

HRT Financial first reported a position in TRAW in Q4 2019 and held it in 6 quarters. The position peaked at $663K in Q1 2021. 22 funds tracked by Wall St. Rank hold TRAW as of Q4 2025.

  • HRT Financial reported no remaining Traws Pharma position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 12,573 Traws Pharma shares in Q4 2025, an estimated $23K.
  • HRT Financial first reported a position in Traws Pharma in Q4 2019 and held it in 6 quarters.
  • HRT Financial's Traws Pharma position peaked at $663K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.